Mobile App: Biogen Idec
Mobile app and market launch guide for Tecfidera, an oral drug treatment for recurring multiple sclerosis.
/bg(ffffff)/960x1242-c.png)
/bg(ffffff)/960x1242-c.png)
/bg(ffffff)/960x1242-c.png)
/bg(ffffff)/960x1242-c.png)
/bg(ffffff)/960x1242-c.png)
/bg(ffffff)/960x1242-c.png)
/bg(ffffff)/960x1242-c.png)
/bg(ffffff)/960x1242-c.png)
/bg(ffffff)/960x1242-c.png)
/bg(ffffff)/960x1242-c.png)
/bg(ffffff)/960x1242-c.png)
/bg(ffffff)/960x1242-c.png)
/bg(ffffff)/960x1242-c.png)
/bg(ffffff)/960x1242-c.png)
/bg(ffffff)/960x1242-c.png)
/bg(ffffff)/960x1242-c.png)
/bg(ffffff)/960x1242-c.png)
/bg(ffffff)/960x1242-c.png)
/bg(ffffff)/960x1242-c.png)
/bg(ffffff)/960x1242-c.png)
/bg(ffffff)/960x1242-c.png)
/bg(ffffff)/960x1242-c.png)
/bg(ffffff)/960x1242-c.png)
/bg(ffffff)/960x1242-c.png)
/bg(ffffff)/960x1242-c.png)
Launch guide
App video
Up Next: